262 related articles for article (PubMed ID: 27246829)
1. Follicular B Lymphomas Generate Regulatory T Cells via the ICOS/ICOSL Pathway and Are Susceptible to Treatment by Anti-ICOS/ICOSL Therapy.
Le KS; Thibult ML; Just-Landi S; Pastor S; Gondois-Rey F; Granjeaud S; Broussais F; Bouabdallah R; Colisson R; Caux C; Ménétrier-Caux C; Leroux D; Xerri L; Olive D
Cancer Res; 2016 Aug; 76(16):4648-60. PubMed ID: 27246829
[TBL] [Abstract][Full Text] [Related]
2. Acute Myeloid Leukemia Cells Express ICOS Ligand to Promote the Expansion of Regulatory T Cells.
Han Y; Dong Y; Yang Q; Xu W; Jiang S; Yu Z; Yu K; Zhang S
Front Immunol; 2018; 9():2227. PubMed ID: 30319662
[TBL] [Abstract][Full Text] [Related]
3. MiR21 sensitized B-lymphoma cells to ABT-199 via ICOS/ICOSL-mediated interaction of Treg cells with endothelial cells.
Zheng Z; Xu PP; Wang L; Zhao HJ; Weng XQ; Zhong HJ; Qu B; Xiong J; Zhao Y; Wang XF; Janin A; Zhao WL
J Exp Clin Cancer Res; 2017 Jun; 36(1):82. PubMed ID: 28637496
[TBL] [Abstract][Full Text] [Related]
4. Augmented ICOS expression in patients with early diffuse cutaneous systemic sclerosis.
Hasegawa M; Fujimoto M; Matsushita T; Hamaguchi Y; Takehara K
Rheumatology (Oxford); 2013 Feb; 52(2):242-51. PubMed ID: 23024058
[TBL] [Abstract][Full Text] [Related]
5. IL-6 and ICOS Antagonize Bim and Promote Regulatory T Cell Accrual with Age.
Raynor J; Karns R; Almanan M; Li KP; Divanovic S; Chougnet CA; Hildeman DA
J Immunol; 2015 Aug; 195(3):944-52. PubMed ID: 26109645
[TBL] [Abstract][Full Text] [Related]
6. Protective Role of ICOS and ICOS Ligand in Corneal Transplantation and in Maintenance of Immune Privilege.
Kunishige T; Taniguchi H; Terada M; Akiba H; Yagita H; Abe R; Hori J
Invest Ophthalmol Vis Sci; 2016 Dec; 57(15):6815-6823. PubMed ID: 28002569
[TBL] [Abstract][Full Text] [Related]
7. ICOS mediates the generation and function of CD4+CD25+Foxp3+ regulatory T cells conveying respiratory tolerance.
Busse M; Krech M; Meyer-Bahlburg A; Hennig C; Hansen G
J Immunol; 2012 Aug; 189(4):1975-82. PubMed ID: 22815292
[TBL] [Abstract][Full Text] [Related]
8. ICOS-ligand expression on plasmacytoid dendritic cells supports breast cancer progression by promoting the accumulation of immunosuppressive CD4+ T cells.
Faget J; Bendriss-Vermare N; Gobert M; Durand I; Olive D; Biota C; Bachelot T; Treilleux I; Goddard-Leon S; Lavergne E; Chabaud S; Blay JY; Caux C; Ménétrier-Caux C
Cancer Res; 2012 Dec; 72(23):6130-41. PubMed ID: 23026134
[TBL] [Abstract][Full Text] [Related]
9. Inducible Co-Stimulator (ICOS) as a potential therapeutic target for anti-cancer therapy.
Amatore F; Gorvel L; Olive D
Expert Opin Ther Targets; 2018 Apr; 22(4):343-351. PubMed ID: 29468927
[TBL] [Abstract][Full Text] [Related]
10. ICOSL expression in human bone marrow-derived mesenchymal stem cells promotes induction of regulatory T cells.
Lee HJ; Kim SN; Jeon MS; Yi T; Song SU
Sci Rep; 2017 Mar; 7():44486. PubMed ID: 28290526
[TBL] [Abstract][Full Text] [Related]
11. Expression of ICOS on human melanoma-infiltrating CD4+CD25highFoxp3+ T regulatory cells: implications and impact on tumor-mediated immune suppression.
Strauss L; Bergmann C; Szczepanski MJ; Lang S; Kirkwood JM; Whiteside TL
J Immunol; 2008 Mar; 180(5):2967-80. PubMed ID: 18292519
[TBL] [Abstract][Full Text] [Related]
12. ICOS regulates the generation and function of human CD4+ Treg in a CTLA-4 dependent manner.
Zheng J; Chan PL; Liu Y; Qin G; Xiang Z; Lam KT; Lewis DB; Lau YL; Tu W
PLoS One; 2013; 8(12):e82203. PubMed ID: 24312642
[TBL] [Abstract][Full Text] [Related]
13. [Influence of anti-ICOS antibody on quantity and function of CD4(+);CD25(+);Foxp3(+);Treg from lymph and blood of rats with bronchial asthma].
Zhao L; Feng XB; Wang YS; Cui QQ; Cao YY
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Oct; 28(10):1029-32. PubMed ID: 23046932
[TBL] [Abstract][Full Text] [Related]
14. ICOS
Nagase H; Takeoka T; Urakawa S; Morimoto-Okazawa A; Kawashima A; Iwahori K; Takiguchi S; Nishikawa H; Sato E; Sakaguchi S; Mori M; Doki Y; Wada H
Int J Cancer; 2017 Feb; 140(3):686-695. PubMed ID: 27756099
[TBL] [Abstract][Full Text] [Related]
15. ICOS/ICOSL upregulation mediates inflammatory response and endothelial dysfunction in type 2 diabetes mellitus.
Zhang HY; Ruan LB; Li Y; Yang TR; Liu WJ; Jiang YX; Li TR; Quan J; Xuan W
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8898-8908. PubMed ID: 30575933
[TBL] [Abstract][Full Text] [Related]
16. Lipopolysaccharide mediated mast cells induce IL-10 producing regulatory T cells through the ICOSL/ICOS axis.
Nie X; Cai G; Zhang W; Wang H; Wu B; Li Q; Shen Q
Clin Immunol; 2012 Mar; 142(3):269-79. PubMed ID: 22154192
[TBL] [Abstract][Full Text] [Related]
17. ADAM10-Mediated ICOS Ligand Shedding on B Cells Is Necessary for Proper T Cell ICOS Regulation and T Follicular Helper Responses.
Lownik JC; Luker AJ; Damle SR; Cooley LF; El Sayed R; Hutloff A; Pitzalis C; Martin RK; El Shikh MEM; Conrad DH
J Immunol; 2017 Oct; 199(7):2305-2315. PubMed ID: 28814605
[TBL] [Abstract][Full Text] [Related]
18. ICOS
Li DY; Xiong XZ
Front Immunol; 2020; 11():2104. PubMed ID: 32983168
[TBL] [Abstract][Full Text] [Related]
19. B cell-specific expression of inducible costimulator ligand is necessary for the induction of arthritis in mice.
Hamel KM; Cao Y; Olalekan SA; Finnegan A
Arthritis Rheumatol; 2014 Jan; 66(1):60-7. PubMed ID: 24449576
[TBL] [Abstract][Full Text] [Related]
20. Deep Flow Cytometry Unveils Distinct Immune Cell Subsets in Inducible T Cell Co-Stimulator Ligand (ICOSL)- and ICOS-Knockout Mice during Experimental Autoimmune Encephalomyelitis.
Raineri D; Abreu H; Vilardo B; Kustrimovic N; Venegoni C; Cappellano G; Chiocchetti A
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]